Position in NVO
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,024,381
+$118,531 QoQ
Shares Held
21,368
-13.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#523
of 1,348 holders
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ridgewood Investments LLC holds $7,132,394 across 7 Drug Manufacturers - General names. NVO ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
39,881 | $2,297,943 | |
| 2 | MRK |
Merck & Co., Inc.
|
9,440 | $1,213,040 | |
| 3 | NVO |
Novo Nordisk A S
This page
|
21,368 | $1,024,381 | |
| 4 | JNJ |
Johnson & Johnson
|
3,558 | $903,625 | |
| 5 | PFE |
Pfizer Inc
|
34,171 | $822,837 | |
| 6 | LLY |
ELI LILLY & Co
|
445 | $533,746 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,666 | $336,822 |
All Filings in NVO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,024,381 | 21,368 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $905,850 | 24,649 | Shares | Sole | 2026-04-03 | |
| 2025-09-30 | $518,609 | 9,346 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $457,395 | 6,627 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $150,684 | 2,170 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $58,063 | 675 | Shares | Sole | 2025-01-10 | |
| 2023-06-30 | $2,265 | 14 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,227 | 14 | Shares | Sole | 2023-04-25 | |
| No filing history on record for this holder in this stock. | ||||||